Loading...
01/10 16:06
Loading...
Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
The earnings call reflects strong financial performance with increased net income and decreased net interest expense. Product development shows potential with AI integration, and market strategy is optimistic despite some uncertainties. Management's reiteration of revenue guidance and successful tariff mitigation efforts are positive indicators. Shareholder return plans are not explicitly mentioned, but overall, the sentiment is positive with a focus on growth and cost efficiency.
Consolidated Revenue Grew more than 9% year-over-year. The growth was achieved despite an uncertain economic environment, driven by strong performance in the Branded Products and Healthcare Apparel segments.
Branded Products Revenue Increased by 14% year-over-year. Growth was driven by the timing of orders delivered, organic expansion with existing large enterprise accounts, and revenues generated by the acquisition of 3 Point in December 2024.
Healthcare Apparel Revenue Grew by 6% year-over-year. The increase was attributed to volume increases in Wink and Carhartt products.
Contact Center Revenue Declined by 3% year-over-year. The decline was due to macroeconomic headwinds, customer downsizing, and attrition outpacing new customer acquisition.
Net Income Per Diluted Share Increased to $0.10 from $0.04 in the prior year period. The improvement was driven by stronger top-line results, maintaining a healthy gross margin, and slight improvement in SG&A as a percentage of sales.
Consolidated Gross Margin Remained flat year-over-year at 38.4%, but improved by 160 basis points sequentially.
SG&A as a Percentage of Sales Improved to 36.3% from 36.9% in the prior year period. The improvement was driven by leverage on the 9% sales increase and cost reduction actions.
EBITDA Increased to $6.1 million from $5.6 million in the prior year period. The increase was due to stronger revenue, steady gross margin, and improved SG&A performance.
Branded Products EBITDA Increased to $9 million from $6.7 million in the prior year period. The improvement was driven by a 100 basis point improvement in gross margin and better SG&A performance.
Healthcare Apparel EBITDA Decreased to $800,000 from $1.3 million in the prior year period. The decline was due to higher costs of goods, including higher tariff costs, despite better SG&A performance.
Contact Center EBITDA Decreased to $1.6 million from $3.2 million in the prior year period. The decline was due to a $1.1 million credit loss reserve resulting from a solar customer bankruptcy and higher SG&A as a percentage of revenues.
Net Interest Expense Decreased to $1.3 million from $1.5 million in the prior year period. The decrease was due to a lower weighted average interest rate.
Net Income Increased to $1.6 million from $600,000 in the prior year period. The improvement was driven by stronger revenue, steady gross margin, and improved SG&A performance.
Branded Products: Achieved 14% growth in Q2 2025, driven by order timing, organic expansion with large accounts, and acquisition of 3 Point in December 2024. Pipeline and order backlog remain strong, with a growing sales team winning new accounts and expanding market share.
Healthcare Apparel: Grew revenues by 6% in Q2 2025, driven by volume increases in Wink and Carhartt products. Investments are being made in digital channels and demand generation for licensed brand products.
Market Share Expansion: Branded Products and Healthcare Apparel segments are expanding market share in their respective industries, with both segments holding single-digit market shares in highly fragmented markets.
Expense Management: Launched an initiative to reduce budgeted expenses in Q2 2025, resulting in improved SG&A as a percentage of sales and stronger profitability.
Sourcing Strategy: Maintained a diverse and redundant sourcing strategy across multiple countries, leveraging own factories in Haiti and negotiating with vendors to manage costs effectively.
Share Repurchase: Repurchased approximately 390,000 shares for $4 million in Q2 2025, with $12.3 million remaining under the buyback authorization.
Contact Center Business: Facing headwinds due to a major customer bankruptcy and slower decision-making from prospective customers. However, the pipeline of opportunities is at a record high, with strong interest in nearshore outsourcing.
Economic Uncertainty: Customer hesitancy due to inflation, interest rates, and tariffs continues to impact business operations, particularly in the Branded Products and Healthcare Apparel segments.
Customer Bankruptcy: A major customer in the solar industry filed for Chapter 11 bankruptcy, negatively affecting the Contact Center segment's revenue and future sales.
Slower Decision-Making: Prospective customers in the Contact Center segment are delaying decisions, slowing the pace of new customer acquisition and revenue generation.
Higher Tariff Costs: Recently enacted higher tariffs have increased costs in the Healthcare Apparel segment, impacting gross margins.
Credit Loss Reserves: $1.8 million in credit loss reserves were recognized due to customer bankruptcies, affecting the Branded Products and Contact Center segments.
Macroeconomic Headwinds: Continued macroeconomic challenges have led to customer downsizing and attrition, particularly in the Contact Center segment.
Revenue Outlook: The company expects full-year revenues to be in the range of $550 million to $575 million, indicating year-over-year growth at the high end of about 2%.
Branded Products Segment: The pipeline of business opportunities and order backlog remain strong. The growing sales team is winning new accounts and expanding market share in a highly fragmented market. The company expects continued expansion in this segment.
Healthcare Apparel Segment: The company is strategically investing in digital channels (wholesale and direct-to-consumer) and aims to spur demand for Wink and Carhartt licensed brand products. Market share in this segment is expected to continue expanding in the long term.
Contact Center Segment: Despite headwinds such as customer bankruptcies and slower decision-making, the company is encouraged by a record pipeline of opportunities and strong interest in nearshore outsourcing. Efforts are focused on closing opportunities quickly.
Expense Management: The company remains focused on expense management and cost reductions, which are expected to position it for stronger profitability in the future.
Capital Allocation: The company has significant liquidity to execute growth plans while continuing share repurchases and maintaining a consistent dividend.
Dividend Consistency: The company continues to maintain a consistent dividend payout as part of its shareholder return strategy.
Share Repurchase Activity: The company actively repurchased approximately 390,000 shares during the second quarter for $4 million, with an average purchase price of $10.26 per share.
Remaining Buyback Authorization: The company has $12.3 million remaining under its current buyback authorization of $17.5 million.
The earnings report shows mixed results: a decline in revenue and margins, but cost savings and a strong Branded Products pipeline. Despite negative trends in the Contact Center and declining EBITDA, optimistic guidance for revenue growth in Q4 and potential acquisitions provide balance. The Q&A highlights challenges in client retention and tariff impacts, but also potential revenue normalization. Without market cap data, the net effect suggests a neutral stock movement, as the positive and negative factors seem to offset each other.
The earnings call reflects strong financial performance with increased net income and decreased net interest expense. Product development shows potential with AI integration, and market strategy is optimistic despite some uncertainties. Management's reiteration of revenue guidance and successful tariff mitigation efforts are positive indicators. Shareholder return plans are not explicitly mentioned, but overall, the sentiment is positive with a focus on growth and cost efficiency.
The earnings call reveals mixed signals: revenue and EPS declined year-over-year, indicating potential challenges. However, the company maintains strong cash flow and plans for share repurchases, which are positive. The Q&A section highlights some uncertainties, particularly around costs and guidance. The acquisition of blue-chip customers offers growth potential, but management's vague responses on key areas like online channels and future margins suggest caution. Overall, the sentiment is neutral, with no strong catalysts for significant stock price movement.
The earnings call revealed mixed signals: revenue growth and share repurchase are positive, but declining EPS, margins, and unclear guidance are concerns. The Q&A highlighted cost pressures and management's evasive responses, further clouding the outlook. The absence of market cap data limits impact assessment, but the overall sentiment is neutral due to offsetting positive and negative factors.
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
